Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
CNS neuroimmunology seen by a neuropathologist.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Stabilometric assessment of context dependent balance recovery in persons with multiple sclerosis: a randomized controlled study.
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Levetiracetam for neuropathic pain in adults.
Multiple sclerosis is primarily a neurodegenerative disease.
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis.
Dynamics and Mechanisms of CNS Myelination.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Identification of Dominant Human Aquaporin 4 T-Cell Epitopes: Observations in Neuromyelitis Optica With Implications for Other Autoimmune DisordershAQP4 T-Cell Epitopes.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
The relationship between muscle pain and fatigue.
Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling.
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
What is the relevance of quality of life assessment for patients with attention impairment?
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
Pages
« first
‹ previous
…
424
425
426
427
428
429
430
431
432
…
next ›
last »